|
The drug, zuranolone, showed improvement in depressive symptoms
among women with postpartum depression at day 15.
It also met its secondary goals, leading to improvement in
symptoms as early as the third day of treatment compared with
placebo.
Postpartum depression occurs after having a baby, with symptoms
similar to depression but which may also include excessive
worrying, crying and feelings of anger.
About 1 in 8 women experience symptoms of postpartum depression,
according to the U.S. Centers of Disease Control and Prevention
(CDC).
The drug is also being developed for the treatment of major
depressive disorder.
(Reporting by Amruta Khandekar; Editing by Devika Syamnath)
[© 2022 Thomson Reuters. All rights
reserved.]
This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|
